Skip to content
★ Sign in to follow
BL

Biosysen Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$434.9MRetail

1 insider bought €1.3M of shares over the last 90 days, the latest by Cheung Ching Mo, filed 24 Sept 2026.

Insider Decl.
21
Thresholds
n/a
Buy Volume
€11M
10 ops. · all time
Sell Volume
€6M
6 ops. · all time

Who traded when

BuySale
Cheung Ching Mo2 buys1 sale
YUAN Fuer1 buy1 sale

Since the insiders bought

  • Filed 11 Sept 2026 · 58 days ago · €1.3M
    +37.7%
    Entry HK$0.17 · Close 04 Nov 2026 HK$0.24
  • Filed 27 Mar 2025 · 591 days ago · €2.8M
    +72.5%
    Entry HK$0.09 · Close at T+365 HK$0.16

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,953 of 26,897 companies
29.4
score / 100
Value
16
Quality
43
FCF yld-11%
Earn yld-9.8%
EV/EBITDA·
ROE·
Gross mgn66%
Net mgn-85%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.24
Analyst consensus
·
Income statement
RevenueHK$51.3M
Gross profitHK$33.7M66% margin
EBITDA-HK$26.8M-52% margin
Net income-HK$43.5M-17.5% margin
Valuation
Beta-0.32
Balance sheet & cash
Market capHK$434.9M
Total debtHK$162.2M
Free Cash Flow-HK$49.6M
Profitability & ownership
ROA-27.2%
% insiders40.5%
% institutions0.0%
Last declaration on 6 November 2026
Declarations21 total
  • ●
    DirectorExecutives
    0HKEX
    906,490,429 sharesShareXHKGHKEX:DA20261105E00459
  • ▲
    DirectorExecutives
    0HKEX
    65,016,254 sharesShareXHKGHKEX:DA20260924E00122
    Canonical exit: 7 Dec 2026 (T+90)
  • ▲
    DirectorExecutives
    12M HKD19HKEX
    172,964,510 shares@ HK$0.068100.0% of flowShareXHKGHKEX:DA20260911E00092
    Canonical exit: 7 Dec 2026 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    193,200,000 sharesShareXHKGHKEX:DA20260119E00323
  • ●
    DirectorExecutives
    0HKEX
    539,129,020 sharesShareXHKGHKEX:DA20251014E00334
  • ▼
    DirectorExecutives
    38M HKD14HKEX
    345,929,020 shares@ HK$0.1128.0% of flowShareXHKGHKEX:DA20251012E00028
  • ▲
    DirectorExecutives
    24M HKD13HKEX
    269,564,510 shares@ HK$0.08818.8% of flowShareXHKGHKEX:DA20250327E00223
    Canonical exit: 25 Jun 2025 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    269,564,510 sharesShareXHKGHKEX:DA20240821E00268
  • ▼
    DirectorExecutives
    670,000 HKD11HKEX
    2,000,000 shares@ HK$0.3350.5% of flowShareXHKGHKEX:DA20240416E00010
  • ▼
    DirectorExecutives
    758,480 HKD11HKEX
    1,996,000 shares@ HK$0.380.6% of flowShareXHKGHKEX:DA20240412E00373
  • ▼
    DirectorExecutives
    8M HKD12HKEX
    32,020,000 shares@ HK$0.256.3% of flowShareXHKGHKEX:DA20240412E00370
  • ▼
    DirectorExecutives
    4M HKD11HKEX
    16,000,000 shares@ HK$0.24843.1% of flowShareXHKGHKEX:DA20240412E00078
  • ▲
    DirectorExecutives
    49M HKD15HKEX
    43,784,000 shares@ HK$1.115235.5% of flowShareXHKGHKEX:DA20180907E00065
    Canonical exit: 4 Dec 2018 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    8,060,000 sharesShareXHKGHKEX:DA20180907E00109
  • ▲
    DirectorExecutives
    111,520 HKD11HKEX
    100,000 shares@ HK$1.11520.1% of flowShareXHKGHKEX:DA20180905E00070
    Canonical exit: 2 Dec 2018 (T+90)
  • ▲
    DirectorExecutives
    2M HKD11HKEX
    2,186,500 shares@ HK$1.11521.8% of flowShareXHKGHKEX:DA20180905E00250
    Canonical exit: 3 Dec 2018 (T+90)
  • ▲
    DirectorExecutives
    69,142 HKD11HKEX
    62,000 shares@ HK$1.11520.1% of flowShareXHKGHKEX:DA20180904E00012
    Canonical exit: 29 Nov 2018 (T+90)
  • ▲
    DirectorExecutives
    7M HKD11HKEX
    5,918,000 shares@ HK$1.11524.8% of flowShareXHKGHKEX:DA20180831E00123
    Canonical exit: 28 Nov 2018 (T+90)
  • ▲
    DirectorExecutives
    1,115 HKD11HKEX
    1,000 shares@ HK$1.11520.0% of flowShareXHKGHKEX:DA20180830E00131
    Canonical exit: 27 Nov 2018 (T+90)
  • ▲
    DirectorExecutives
    568,752 HKD11HKEX
    510,000 shares@ HK$1.11520.4% of flowShareXHKGHKEX:DA20180829E00214
    Canonical exit: 25 Nov 2018 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    269,019,010 sharesShareXHKGHKEX:DA20180816E00026

21 of 21 declarations

About Biosysen Ltd.

YUAN Fuer, Director of Biosysen Ltd., lies behind the largest amounts: a purchase of EUR 5,346,169 on September 5, 2018, another of EUR 2,839,153 on March 27, 2025, but also the largest sales, EUR 4,227,294 on October 9, 2025, EUR 950,890 on April 10, 2024 and EUR 467,374 on April 9, 2024. Cheung Ching Mo (Director) bought EUR 1,289,305 on September 8, 2026.

In all, 10 purchases (9 with an amount) come to EUR 10,545,429, with a median of EUR 268,076, and 6 sales (5 with an amount) to EUR 5,815,461, with a median of EUR 467,374, so purchases make up 63% of open-market trades. YUAN Fuer lodges 15 of the 20 filings, of which 8 purchases and 5 sales.

Read moreShow less

The history is discontinuous: 9 filings in 2018, then 5 in 2024, 3 in 2025 and 3 in 2026, published a median of 2 days after the trade. The 3 filings of the last twelve months count 2 purchases and 1 sale. The Hong Kong retail company, listed in Hong Kong, is worth HKD 375,815,520, of which 40.5% is held by insiders.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations